RDL works to provide the most helpful studies and research for health care professionals.

• Shen G, Metzger A, Wallace D*, Correia P, and Morris R
  Anti-C1q specific IgG antibodies in SLE patients and other disease groups
  Arthritis Rheum. 2004; 50 (supplement): S600 –S601.
• Wu R, Owen GC, Liu T, Shen G and Morris R
  Significance of the detection of HIV-1 gag- and /or pol-CD8/A2 T-lymphocytes in HIV-patients
  Immunology Letters. 2005; 98: 73-81.
• Wu R, Shen GQ, Morris R, Patnaik M, and Peter JB
  Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and cardial infarction
  J Autoimmunity. 2005; 15: 1-8.
• Shen G and Morris R et al
  RNA polymerase I/III autoantibodies in System Sclerosis and different disease groups
  Clinical Chemistry. 2005; 51 (6 suppl): A89
• Shen G, Morris R, Wallace D, Correia P, Lehrhoff  L, and Metzger A
  Anti-alpha-fodrin specific IgA antibodies in Sjogren’s Syndrome (SS) and other autoimmune diseases
  Clinical Chemistry. 2005; 51 (6 suppl): A121.
• Lienesch DW, Sherman KE, Metzger A, and Shen
  Anti-C1q antibodies in patients with chronic hepatic C infection
  Arthritis Rheum. Submitted.
• Wu R, Shen GQ, Morris R, Patnaik M, Peter JB
  Elevated Levels of Autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine (oxPAPC) in patients with hypertension and myocardial infarction
  J Autoimmunity. 2005;24:349-56.
• Lienesch DW, Sherman KE, Metzger A and Shen GQ
  Anti-C1q antibodies in patients with chronic hepatitis C Infection
  Clin Exp Rheumatol. 2006; 24: 183-5.
• Shen GQ, Song Y, Metzger A, Correia P and Morris R
  Anti-neuronal antibodies in CNS-SLE patients and other autoimmune diseases
  Arthritis Rheumatism 2006; 54: S292.
• Kang EH, GQ Shen, Morris R, Metzger A, Lee EY, Song YW
  Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases
  Lupus. 2008; 17:21-25.
• In-house study comparing the ability of newer generation anti-dsDNA ELISA assays to follow SLE disease activity relative to the Farr Assay.
• Shen, G, et al
  “RNA polymerase I/III autoantibodies in systemic sclerosis and different disease groups”
  Clinical Chemistry, Vol. 51, No. 6 (Supplement), A89, 2005.
• Shen, G, et al
  “Anti-alpha-fodrin specific IgA antibodies in Sjogren’s Syndrome and other autoimmune diseases”
  Clinical Chemistry, Vol. 51, No. 6 (Supplement), A121, 2005.
• Wu, R, et al
  “Elevated levels of autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine (oxPAPC) in patients with hypertension and myocardial infarction”
  J Autoimmunity, Vol. 24, 349-56, 2005.
• In-house study comparing the sensitivity and specificity of the third generation versus second generation anti-ccp assay in 540 Rheumatoid Arthritis, autoimmune disease group and normal control samples from our serum bank.
• Hueber W, et al
  “Proteomic analysis of secreted proteins in early rheumatoid arthritis: Anti-citrulline reactivity is associated with upregulation of proinflammatory cytokines,”
  Ann Rheum Dis published online 10 Aug 2006.
• In-house study utilizing 1500 patient samples from our serum bank to compare the clinical utility of the commercially available bead-based autoimmune multiplex assays versus established methods (IFA, RIA and ELISA).
• Shen, GQ, et al
  “Anti-neuronal antibodies in CNS-SLE patients and other autoimmune diseases”
  Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S292-3, 2006.
• Ishimori, ML, et al
  “Screening for autoantibodies: the significance of ANA titer and its relationship to other autoantibodies”
  Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S441-2, 2006.